Valuation Sernova Biotherapeutics Inc
Stocks
SVA
CA81752F1062
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Toronto S.E.
2026-10-19
|
5-day change | 1st Jan Change | ||
| 0.1150 CAD | 0.00% |
|
0.00% | -11.54% |
Company Valuation: Sernova Biotherapeutics Inc
Data adjusted to current consolidation scope
| Fiscal Period: October | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 326.4 | 234.5 | 243.9 | 81.33 | 59.26 | 43.43 | - | - |
| Change | - | -28.16% | 3.99% | -66.65% | -27.14% | -26.71% | - | - |
| Enterprise Value (EV) | 326.4 | 234.5 | 235.1 | 75.79 | 63.76 | 43.43 | 43.43 | 43.43 |
| Change | - | -28.16% | 0.27% | -67.77% | -15.87% | -31.89% | 0% | 0% |
| P/E | -41.7x | -8.89x | -5.85x | -2.5x | -3x | -4.6x | -3.83x | -2.3x |
| PBR | - | - | 18.4x | -6.28x | -1.96x | - | - | - |
| PEG | - | -0x | -0.1x | 0.1x | 0.1x | 0.1x | -0.2x | -0x |
| Capitalization / Revenue | - | - | - | - | - | - | 17.4x | 0.34x |
| EV / Revenue | - | - | - | - | - | - | 17.4x | 0.34x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -4.72x | -3.65x | -2.3x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.03 | -0.09 | -0.13 | -0.1 | -0.05 | -0.025 | -0.03 | -0.05 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | - | 2.5 | 127.8 |
| EBITDA | -6.669 | -24.31 | -40.06 | -31.12 | -14.68 | - | - | - |
| EBIT 1 | -6.937 | -24.75 | -40.5 | -31.66 | -15.02 | -9.2 | -11.9 | -18.9 |
| Net income 1 | -6.966 | -24.42 | -39 | -32.19 | -15.74 | -11.3 | -13.9 | -20.9 |
| Net Debt | - | - | -8.722 | -5.544 | 4.503 | - | - | - |
| Reference price 2 | 1.2500 | 0.8000 | 0.7600 | 0.2500 | 0.1500 | 0.1150 | 0.1150 | 0.1150 |
| Nbr of stocks (in thousands) | 261,133 | 293,125 | 320,857 | 325,325 | 395,037 | 377,643 | - | - |
| Announcement Date | 2/14/22 | 1/26/23 | 1/29/24 | 12/23/24 | 12/19/25 | - | - | - |
1CAD in Million2CAD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -4.6x | - | - | - | 30.7M | ||
| 30.95x | 4.09x | 15.82x | 2.45% | 181B | ||
| 20.26x | 3.52x | 12.59x | 2.99% | 116B | ||
| 22.98x | 4.5x | 15.69x | 1.22% | 113B | ||
| 27.35x | 2.68x | 10.75x | 2.64% | 79.83B | ||
| 18.7x | 0.22x | 13.49x | 0.7% | 65.06B | ||
| 31.17x | 7.75x | 19.98x | 1.28% | 54.35B | ||
| 36.95x | 3.53x | 12.1x | 2.05% | 52.23B | ||
| 37.95x | 9.42x | 26.36x | -.--% | 44.15B | ||
| 34.57x | 6.06x | 19.03x | -.--% | 32.47B | ||
| Average | 25.63x | 4.64x | 16.20x | 1.48% | 73.86B | |
| Weighted average by Cap. | 27.60x | 4.20x | 15.35x | 1.84% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- SVA Stock
- Valuation Sernova Biotherapeutics Inc
Select your edition
All financial news and data tailored to specific country editions
















